Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma

Table 2

Analgesic use and risk of first primary invasive or In situ melanoma.

Exposure	Patients	Controls	Total	Crude OR (95% CI)	Adjusted OR (95% CI)
Ever use of aspirin:
Yes	31	13	44	0.854 (0.431–1.693)	1.447 (0.442–4.736)
No	296	106	402
Ever use of nonaspirin NSAIDs:
Yes	29	17	46	0.584 (0.308–1.107)	0.710 (0.234–2.024)
No	298	102	400
Ever use of acetaminophen:
Yes	6	3	9	0.723 (0.178–2.937)	Not assessed
No	321	116	437

OR Odds ratio; CI Confidence interval; NSAIDs Nonsteroidal anti-inflammatory drugs.